Vantas



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 51.7%
Prostate Cancer 35.3%
Pain 1.7%
Palliative Care 1.7%
Vitamin Supplementation 1.7%
Constipation 1.3%
Prostate Cancer Metastatic 1.3%
Anticoagulant Therapy 0.8%
Arthropathy 0.8%
Hypertension 0.8%
Precocious Puberty 0.8%
Blood Testosterone 0.4%
Deep Vein Thrombosis 0.4%
Insomnia 0.4%
Osteoporosis 0.4%
Prostatic Specific Antigen Abnormal 0.4%
Urinary Retention 16.1%
Procedural Complication 14.3%
Device Breakage 12.5%
Oedema Peripheral 7.1%
Death 5.4%
Prostatic Specific Antigen Increased 5.4%
Implant Site Cellulitis 3.6%
Implant Site Necrosis 3.6%
Muscle Spasms 3.6%
Prostate Cancer 3.6%
Rash Pruritic 3.6%
Urinary Hesitation 3.6%
Vomiting 3.6%
Wrong Drug Administered 3.6%
Arthralgia 1.8%
Basal Ganglia Haemorrhage 1.8%
Bladder Cancer 1.8%
Cellulitis 1.8%
Chills 1.8%
Chondropathy 1.8%
Secondary
Prostate Cancer 52.9%
Product Used For Unknown Indication 41.2%
Palliative Care 5.9%
Procedural Complication 30.0%
Death 20.0%
Heart Rate Increased 10.0%
Implant Site Fibrosis 10.0%
Prostate Cancer Recurrent 10.0%
Tenderness 10.0%
Weight Decreased 10.0%
Concomitant
Hypertension 14.4%
Prostate Cancer Metastatic 10.1%
Diabetes Mellitus 8.9%
Multiple Allergies 8.6%
Medical Diet 5.2%
Cancer Hormonal Therapy 4.6%
Hyperlipidaemia 4.4%
Arteriosclerosis 4.3%
Cardiovascular Event Prophylaxis 4.3%
Coronary Artery Disease 4.3%
Rosacea 4.3%
Chronic Obstructive Pulmonary Disease 4.0%
Oedema Peripheral 3.4%
Prophylaxis 3.2%
Hyperuricaemia 3.1%
Back Pain 2.9%
Cancer Pain 2.8%
Oedema 2.8%
Musculoskeletal Pain 2.5%
Bronchitis 2.1%
Hyperuricaemia 76.5%
Blood Uric Acid Increased 5.9%
Osteonecrosis Of Jaw 5.9%
Diarrhoea 2.9%
Parkinson's Disease 2.9%
Squamous Cell Carcinoma 2.9%
Ureteric Stenosis 2.9%